Alumni

Includes Name, Year, Program

2004

Anna Blobaum, PhD

Ctr for Neuroscience Drug Disc, Vanderbilt University
Research Assistant Professor
annie.blobaum@vanderbilt.edu

Jennifer Harrell, PhD

Science Department, Community College of Aurora
Faculty
jennifer.harrell@ccaurora.edu

Emily Jutkiewicz, Ph.D.

Pharmacology
University of Michigan
Associate Professor
ejutkiew@umich.edu

Dyke McEwen, PhD

University of Michigan
Research Area Specialist
dmcewen@umich.edu

2003

Kathryn Chadman

Behavioral Pharmacology Laboratory, The Institute for Basic Research, OPWDD
Head
kathryn.chadman@opwdd.ny.gov

Monica Chu

Chemistry Department, Ursinus College
Lecturer in Chemistry
mchu@ursinus.edu

Patrick Murphy

College of Nursing, Seattle University
Associate Professor
murphyp@seattleu.edu

Blaine Robinson

Therapy Acceleration Program at the Leukemia & Lymphoma Society
Senior Director
blainerobinson76@yahoo.com

2002

Hassan Dhaini

University of Balamand, Lebanon
Toxicologist, Researcher, and Director

Shefali Kakar (Malhotra)

Novartis
Senior Director, clinical Pharmacology
smalhotr@umich.edu

Kimon Kanelakis

Toxicology Team, FDA
Pharmacologist
kimon.kanelakis@fda.hhs.gov

James Novak

Henry Ford Health System
Physician

Huailing Zhong

U-Pharm Laboratories
President and Co-Founder

2001

Andrew Bender

Life Sciences Eisai Research Institute
Research Investigator

Daniel Broom

Lignumus LLC, Covidien
Owner, Director, R&D

Duane Chung

Algaeneers Inc; Neemo Inc.
Chairman and CEO; Executive Chairman
dwing@umich.edu

Damon Demady

Novartis Institutes for Biomedical Research
Safety Assessment Expert

Daniel Hamstra, MD, Ph.D.

Baylor College of Medicine
William T. Butler Professor and Chairman of Radiation Oncology
dhamm@umich.edu

Lee Koetzner

Product Safety Labs
Senior Study Director
leekoetzner@productsafetylabs.com

William Lim

University Malaysia
Associate Professor
kslim@fmhs.unimas.my

Leo Ostruszka

BD Biosciences
Staff Scientist
ljostrus@umich.edu

Jennifer Vuletich Stanley

PROlific Research Consulting, LLC
Independent clinical research/medical writing consultant

2000

Andrew Alt, Ph.D.

Pharmacology
LSI, University of Michigan
Director, Center for Chemical Genomics
andyalt@umich.edu

Jordan Fridman

Incyte Corp.
Director, Pharmacology
jfridman@incyte.com

Hani Houshyar

Biogen
Director, Early Stage Pipeline Leadership

Thomas Hullinger

ProNAi Therapeutics, Inc.
Senior Director of Translational Research

Daniel Linseman

University of Denver
Associate Professor
daniel.linseman@du.edu

Noune Sarvazyan

Artann Laboratories Inc.
Chief Executive Officer

Elaine Tanhehco

John Teiber

UT Southwestern Medical Center
Assistant Professor
john.teiber@utsouthwestern.edu

1999

Christiaan Brink

North-West University
Professor
tiaan.brink@mwc.ac.za

Kurt Dittmar

John Muir Medical Center Concord Campus
Chief of Anesthesiology
kdittmar@gmail.com

Elizabeth Glaze

Chemopreventive Agent Development Research Group, NIH
Regulatory Affairs Specialist
elizabeth.glaze@nih.gov

Keng-Li Lan

Institute of Traditional Medicine, National Yang-Ming University
Associate Professor
kllan@vghtpe.gov.tw

Kim McGinnis

Pueblo of Pojoaque Tribal Court
Chief Judge
kmcginnis@pojoaque.org

Adam Silverstein

United Therapeutics Corporation
Director, Nonclinical Development
asilverstein1@gmail.com

Pages